Challenges for the oral delivery of macromolecules
Top Cited Papers
- 1 April 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 2 (4), 289-295
- https://doi.org/10.1038/nrd1067
Abstract
The rapid integration of new technologies by the pharmaceutical industry has resulted in numerous breakthroughs in the discovery, development and manufacturing of pharmaceutical products. In particular, the commercial-scale production of high-purity recombinant proteins has resulted in important additions to treatment options for many large therapeutic areas. In addition to proteins, other macromolecules, such as the animal-derived mucopolysaccharide heparins, have also seen dramatic growth as injectable pharmaceutical products. To date, macromolecules have been limited as therapeutics by the fact that they cannot be orally delivered. This article will address the current status and future possibilities of oral macromolecular drug delivery.Keywords
This publication has 78 references indexed in Scilit:
- Novel drug development opportunities for heparinNature Reviews Drug Discovery, 2002
- PeroralRoute: An Opportunity for Protein and Peptide Drug DeliveryChemical Reviews, 2001
- Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?European Journal of Pharmaceutics and Biopharmaceutics, 2000
- Advances in the oral delivery of proteinsExpert Opinion on Therapeutic Patents, 1999
- Advances in the oral delivery of proteinsExpert Opinion on Therapeutic Patents, 1998
- Biologically erodable microspheres as potential oral drug delivery systemsNature, 1997
- Degradation of Insulin and Calcitonin and Their Protection by Various Protease Inhibitors in Rat Caecal Contents: Implications in Peptide Delivery to the ColonJournal of Pharmacy and Pharmacology, 1997
- Oral colon-specific drug delivery: a reviewDrug Delivery, 1995
- Approaches and Opportunities in Colon-Specific Drug DeliveryCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- Absorption of Polyethylene Glycols 600 Through 2000: The Molecular Weight Dependence of Gastrointestinal and Nasal AbsorptionPharmaceutical Research, 1990